- Antigen component of IVX-411 found to be unstable; issue specific to molecule, with no evidence of read-through to other Icosavax programs -
- Now focused on a bivalent strategy for COVID-19 candidate development displaying computationally engineered RBD antigens; provides optionality as a potential future component of combination vaccines –
Read more at globenewswire.com